Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | HPGD | P15428 | 4/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | ALB | P02768 | 1/20 | 0.67 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.67 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | TUBB | P07437 | 1/20 | 0.66 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.66 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.66 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.66 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.66 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.66 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.66 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.66 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.66 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.66 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.66 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Marbofloxacin SCHEMBL29355042 | 1.00 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10ALB | |
| Marbofloxacin SCHEMBL10563057 | 0.99 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10ALB | |
| SCHEMBL12637996 | 0.97 | KDM4E (0.94) | KDM4EALDH1A1HPGDHSD17B10ALB | |
| Marbofloxacin SCHEMBL1768472 | 0.96 | KDM4E (0.93) | KDM4EALDH1A1HPGDHSD17B10ALB | |
| SCHEMBL16518628 | 0.92 | KDM4E (0.85) | KDM4EALDH1A1HPGDHSD17B10ALB | |
| SCHEMBL9533526 | 0.91 | KDM4E (0.84) | KDM4EALDH1A1HPGDHSD17B10ALB | |
| SCHEMBL12665530 | 0.91 | KDM4E (0.84) | KDM4EALDH1A1HPGDHSD17B10ALB | |
| SCHEMBL9533821 | 0.91 | KDM4E (0.83) | KDM4EALDH1A1HPGDHSD17B10ALB | |
| SCHEMBL10700294 | 0.90 | KDM4E (0.82) | KDM4EALDH1A1HPGDHSD17B10ALB | |
| SCHEMBL10561493 | 0.90 | KDM4E (0.82) | KDM4EALDH1A1HPGDHSD17B10ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3446 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079888-A | Marbofloxacin intermediate | — | 2026-05-26 | — | — | CN | claimed |
| US-12624057-B2 | Bisphosphonate quinolone conjugates and uses thereof | BIOVINC, LLC (US) | 2026-05-12 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20260060990-A1 | OTIC FORMULATIONS, METHODS AND DEVICES | DECHRA VETERINARY PRODUCTS LLC (US) | 2026-03-05 | — | — | US | claimed |
| US-12491189-B2 | OTIC formulations, methods and devices | DECHRA VETERINARY PRODUCTS, LLC (US) | 2025-12-09 | — | — | US | claimed |
| US-12480089-B2 | Antiviral treatment comprising Blis containing probiotic products | BLIS TECHNOLOGIES LIMITED (NL) | 2025-11-25 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| US-6114351-A | N-oxides as antibacterial agents | BAYER AKTIENGESELLSCHAFT (DE) | 2000-09-05 | — | — | US | claimed |
| CN-1209065-A | Otic microbial combinations | BAYER AG (US) | 1999-02-24 | — | — | CN | claimed |
| EP-0869795-A1 | OTIC MICROBIAL COMBINATIONS | Bayer Corporation (US) | 1998-10-14 | — | — | EP | claimed |
| CN-1190958-A | Novel antimicrobial compositions | BAYER AG (DE) | 1998-08-19 | — | — | CN | claimed |
| US-5756506-A | ADMINISTERING TO ANIMALS IN TREATMENT OF BACTERIAL INFECTIONS | BAYER CORPORATION (US) | 1998-05-26 | — | — | US | claimed |
| EP-0828715-A1 | N-OXIDES AS ANTIBACTERIAL AGENTS | BAYER AG (DE) | 1998-03-18 | — | — | EP | claimed |
| WO-1997024128-A1 | OTIC MICROBIAL COMBINATIONS | BAYER CORPORATION (US) | 1997-07-10 | — | — | WO | claimed |
| WO-1996038417-A1 | N-OXIDES AS ANTIBACTERIAL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-12-05 | — | — | WO | claimed |
| EP-0259804-B1 | Pyrido[3,2,1-ij]-1,3,4-benzoxadiazine derivatives, process for their preparation, resulting pharmaceutical preparations and intermediates for use in the process | HOFFMANN LA ROCHE (CH) | 1993-11-18 | — | — | EP | claimed |
| EP-0259804-A2 | Pyrido[3,2,1-ij]-1,3,4-benzoxadiazine derivatives, process for their preparation, resulting pharmaceutical preparations and intermediates for use in the process | F. HOFFMANN-LA ROCHE AG (CH) | 1988-03-16 | — | — | EP | claimed |